The global CAR T-cell therapy market is poised for significant growth, with its size projected to increase from USD 4.6 billion in 2024 to USD 15.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 11.4% during this period. This expansion is driven by advances in innovative technology platforms, substantial funding, and encouraging clinical trial outcomes, positioning CAR...